Welcome to LookChem.com Sign In|Join Free
  • or
(E)-methyl 2-((2S,6S)-2-((E)-4-((2R,6S)-6-(((2S,4S,6S)-4-acetoxy-6-((R)-2-(tert-butyldiphenylsilyloxy)-4-(tert-butylthio)-4-oxobutyl)-2-methoxy-3,3-dimethyltetrahydro-2H-pyran-2-yl)methyl)-4-methylenetetrahydro-2H-pyran-2-yl)-2-methylbut-3-en-2-yl)-6-((2R,3R)-3-(benzyloxymethoxy)-2-(4-methoxybenzyloxy)butyl)-2-methoxy-3-oxo-2H-pyran-4(3H,5H,6H)-ylidene)acetate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1103935-84-7

Post Buying Request

1103935-84-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1103935-84-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1103935-84-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,0,3,9,3 and 5 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1103935-84:
(9*1)+(8*1)+(7*0)+(6*3)+(5*9)+(4*3)+(3*5)+(2*8)+(1*4)=127
127 % 10 = 7
So 1103935-84-7 is a valid CAS Registry Number.

1103935-84-7Upstream product

1103935-84-7Relevant academic research and scientific papers

Substitution on the A-ring confers to bryopyran analogues the unique biological activity characteristic of bryostatins and distinct from that of the phorbol esters

Keck, Gary E.,Poudel, Yam B.,Welch, Dennie S.,Kraft, Matthew B.,Truong, Anh P.,Stephens, Jeffrey C.,Kedei, Noemi,Lewin, Nancy E.,Blumberg, Peter M.

supporting information; experimental part, p. 593 - 596 (2009/09/27)

(Chemical Equation Presented) A close structural analogue of bryostatin 1, which differs from bryostatin 1 only by the absence of the C30 carbomethoxy group (on the C13 enoate of the B-ring), has been prepared by total synthesis. Bio

MACROCYCLIC COMPOUNDS AND METHODS OF MAKING AND USING THEREOF

-

Page/Page column 64; 70-71; 7/26, (2009/12/02)

Described herein are tricyclic macrolactones. The macrolactones have a high binding affinity for PKC. The compounds described herein can be used in a number of therapeutic applications including cancer and Alzheimer's prevention and treatment. The compounds described herein can also treat memory loss. Also described herein are methods for producing macrolactones. The methods permit the high-yield synthesis of macrolactones in fewer steps and with a higher degree of substitution and specificity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1103935-84-7